Tuxedo, NY, United States of America

Bryan R Wilson

This inventor holds 1 USPTO granted patent. Top assignee: Pharmaceutical Discovery Corporation. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bryan R Wilson. Retrieved from https://idiyas.com/inventor/bryan-r-wilson-0ny9w5fb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Bryan R. Wilson

Introduction

Bryan R. Wilson is an accomplished inventor based in Tuxedo, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological disorders. His innovative work has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Bryan R. Wilson holds a patent for a muscarinic M₂ receptor ligand designed for the treatment of neurological disorders. This invention focuses on ligands that can be administered with minimal side effects, enhancing patient safety and comfort. The patent also includes a method for synthesizing these compounds, showcasing his expertise in pharmaceutical development.

Career Highlights

Wilson is currently associated with Pharmaceutical Discovery Corporation, where he applies his knowledge and skills to advance drug discovery and development. His work is pivotal in creating effective treatments that can improve the quality of life for individuals suffering from neurological conditions.

Collaborations

Throughout his career, Wilson has collaborated with notable colleagues, including R. Tyler McCabe and Christopher A. Rhodes. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Bryan R. Wilson's contributions to the field of pharmaceuticals, particularly through his patent for muscarinic M₂ receptor ligands, highlight his commitment to improving healthcare. His work continues to inspire advancements in the treatment of neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…